May 8, 2023Open Access

The incidence and prevalence of IgA nephropathy in Europe

Key Points

Key points are not available for this paper at this time.

Abstract

Based on high-quality data from European national registries, IgAN point prevalence was estimated at 2.53 per 10 000 in patients of all ages. Prevalence was considerably lower in pediatric and elderly populations.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Willey et al. (Mon,) studied this question.

synapsesocial.com/papers/69d90348bfc0898f4bd17d76 https://doi.org/https://doi.org/10.1093/ndt/gfad082

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Mortality in Patients With IgA Nephropathy2013 · 70 citations
2Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments2014 · 496 citations
3Frequency of renal diseases and clinical indications for renal biopsy in children (report of the Italian National Registry of Renal Biopsies in Children). Group of Renal Immunopathology of the Italian Society of Pediatric Nephrology and Group of Renal Immunopathology of the Italian Society of Nephrology.1998 · 172 citations
4Proteinuria screening for children2005 · 72 citations
5Life expectancy and disease burden in the Nordic countries: results from the Global Burden of Diseases, Injuries, and Risk Factors Study 20172019 · 111 citations

Bookmark

View Full Paper